These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38466750)

  • 1. Advancing Diagnosis of Current Hepatitis C Virus Infection: A Key to Hepatitis C Elimination in the United States.
    Kamili S; Wester C
    J Infect Dis; 2024 May; 229(Supplement_3):S313-S315. PubMed ID: 38466750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opportunities for Enhanced Prevention and Control of Hepatitis C Through Improved Screening and Testing Efforts.
    Cartwright EJ; Patel PR
    J Infect Dis; 2024 May; 229(Supplement_3):S350-S356. PubMed ID: 37739791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDC's New Hepatitis C Virus Testing Recommendations for Perinatally Exposed Infants and Children: A Step Towards Hepatitis C Elimination.
    Panagiotakopoulos L; Miele K; Cartwright EJ; Kamili S; Furukawa N; Woodworth K; Tong VT; Kim SY; Wester C; Sandul AL
    J Womens Health (Larchmt); 2024 Jun; 33(6):695-701. PubMed ID: 38476092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vital signs: evaluation of hepatitis C virus infection testing and reporting - eight U.S. sites, 2005-2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 May; 62(18):357-61. PubMed ID: 23657111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDC Recommendations for Hepatitis C Testing Among Perinatally Exposed Infants and Children - United States, 2023.
    Panagiotakopoulos L; Sandul AL; ; Conners EE; Foster MA; Nelson NP; Wester C;
    MMWR Recomm Rep; 2023 Nov; 72(4):1-21. PubMed ID: 37906518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated Operational Guidance for Implementing CDC's Recommendations on Testing for Hepatitis C Virus Infection.
    Cartwright EJ; Patel P; Kamili S; Wester C
    MMWR Morb Mortal Wkly Rep; 2023 Jul; 72(28):766-768. PubMed ID: 37440452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing for HCV infection: an update of guidance for clinicians and laboratorians.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 May; 62(18):362-5. PubMed ID: 23657112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
    Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
    J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-Classification of Hepatitis C Virus Diagnostics: Implications for Screening and Diagnosis.
    Terrault N
    J Infect Dis; 2024 May; 229(Supplement_3):S322-S327. PubMed ID: 37739784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons Learned From Global Hepatitis C Elimination Programs.
    Handanagic S; Shadaker S; Drobeniuc J; Tsereteli M; Alkhazashvili M; Adesigbin C; Adamu I; Adabe R; Agwuocha C; Adisa O; Azania A; Boeke CE; Ngwije A; Serumondo J; Armstrong PA
    J Infect Dis; 2024 May; 229(Supplement_3):S334-S341. PubMed ID: 37739781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pragmatic Experience with Risk-based versus Universal Hepatitis C Screening in Pregnancy: Detection of Infection and Postpartum Linkage to Care.
    Bushman ET; Subramani L; Sanjanwala A; Dionne-Odom J; Franco R; Owen J; Subramaniam A
    Am J Perinatol; 2021 Sep; 38(11):1109-1116. PubMed ID: 33934324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Centers for Disease Control and Prevention Recommendations for Hepatitis C Virus Testing in an Urban Emergency Department.
    Hsieh YH; Rothman RE; Laeyendecker OB; Kelen GD; Avornu A; Patel EU; Kim J; Irvin R; Thomas DL; Quinn TC
    Clin Infect Dis; 2016 May; 62(9):1059-65. PubMed ID: 26908800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancing Hepatitis C Elimination through Opt-Out Universal Screening and Treatment in Carceral Settings, United States.
    McNamara M; Furukawa N; Cartwright EJ
    Emerg Infect Dis; 2024 Apr; 30(13):S80-S87. PubMed ID: 38561831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximizing Reflexive Hepatitis C Virus (HCV) RNA Testing of HCV Antibody-Reactive Samples Within United States Public Health Laboratories.
    Johnson LN; Gaynor AM; Wroblewski K; Buss SN
    J Infect Dis; 2024 May; 229(Supplement_3):S357-S361. PubMed ID: 37739790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Urgent Need to Implement Point-of-Care RNA Testing for Hepatitis C Virus to Support Elimination.
    Kapadia SN; Jordan AE; Eckhardt BJ; Perlman DC
    Clin Infect Dis; 2024 May; 78(5):1235-1239. PubMed ID: 37633653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing strategies for hepatitis C testing.
    Teo CG
    Antivir Ther; 2012; 17(7 Pt B):1391-5. PubMed ID: 23322655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV and hepatitis C virus infection in the United States: whom and how to test.
    Panneer N; Lontok E; Branson BM; Teo CG; Dan C; Parker M; Stekler JD; DeMaria A; Miller V
    Clin Infect Dis; 2014 Sep; 59(6):875-82. PubMed ID: 24867787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30.
    Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Bulterys M; Ball A; Hirnschall G
    Lancet Glob Health; 2019 Sep; 7(9):e1180-e1188. PubMed ID: 31353061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites.
    Smith BD; Teshale E; Jewett A; Weinbaum CM; Neaigus A; Hagan H; Jenness SM; Melville SK; Burt R; Thiede H; Al-Tayyib A; Pannala PR; Miles IW; Oster AM; Smith A; Finlayson T; Bowles KE; Dinenno EA
    Clin Infect Dis; 2011 Oct; 53(8):780-6. PubMed ID: 21921221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.